CEO & Portfolio manager at JC Clark Investments Ltd.
Member since: Feb '08 · 1386 Opinions
Obviously, Canadian market valuations are a bit lower because we have a weaker economy here. In the US, however, valuations are at almost two-decade-level highs. We have to go back to 1999-2000 to see these types of elevated valuations. Some of that is driven by the tech sector, which has seen really strong results, but even the forward-looking multiple on the broad S&P 500 is 22-23x.
That, combined with all the uncertainty, tariff risk, and general unpredictability of the Trump administration, gives him pause on the US market. He's not calling for a huge correction necessarily, just that it makes sense for investors to be more careful where they're allocating capital. Perhaps look for value-type names trading at lower multiples and predictable cashflow.
Right now, he tends to favour the Canadian market, which people are down on. Thinks we might be at the maximum point of pessimism as it relates to the Canadian market.
Valuations are low in Canadian equities. Canada is somewhat likely to get a new federal leader, and deregulation and tax cuts in the US are going to force Canada into somewhat more business-friendly policies.
Investors really need to analyze each company case-by-case. Businesses that are purely domestic shouldn't be impacted by tariffs. Businesses to do with the auto sector are potentially very exposed. There are other Canadian companies that have revenue, people, and facilities in the US; they aren't actually exporting goods from Canada, so it makes them less vulnerable to tariff risk.
Now has ~3-4% market share in Canada. Lots of opportunity to expand, as Canadian market is more fragmented than, say, the US. Entirely domestic, not exposed to tariffs. Essential service, most patients have insurance. Market didn't love its equity issue; stock's down 20%, so he's been adding. Good insider ownership.
Great business. Benefits from online shopping and move to cashless. Trades at a premium valuation, so good news already built in. Best time to buy a blue-chip like this is on a market correction. Always regulatory risk, but Canada putting a cap on interest rates would not materially affect this name.